Myelin expression is altered in the brains of neonatal rats reared in a fluctuating oxygen atmosphere

Neonatology

Volumn 94, Issue 2, 2008, Pages 113-122

  Sedowofia, Kofi ^a   Giles, David ^a   Wade, Jean ^a   Cunningham, Steve ^a   McColm, Janet R ^a   Minns, Robert ^a   McIntosh, Neil ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Active caspase 3; Glial fibrillary acidic protein; Myelin basic protein; Myelination; Preterm brain injury

Indexed keywords

CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATMOSPHERE; BRAIN CORTEX; BRAIN INJURY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; HYPOTHALAMUS; NEWBORN; NONHUMAN; OXYGEN BLOOD LEVEL; OXYGEN SUPPLY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CASPASE 3; CELL COUNT; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPEROXIA; IMMUNOENZYME TECHNIQUES; MYELIN BASIC PROTEINS; NERVE FIBERS, MYELINATED; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 49449119128     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000119721     Document Type: Article

References (60)

1. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR: Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343:378-384.
2. Vohr BR, Wright LL, Dusick AM, Mele L, Verter J, Steichen JJ, et al: Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216-1226.
3. Botting N, Powls A, Cooke RW, Marlow N: Cognitive and educational outcome of very-low-birthweight children in early adolescence. Dev Med Child Neurol 1998;40:652-660.
4. Botting N, Powls A, Cooke RW, Marlow N. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiatry 1997;38:931-941.
5. Hoekstra RE, Ferrara TB, Couser RJ, Payne NR, Connett JE: Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23-26 weeks' gestational age at a tertiary center. Pediatrics 2004;113:e1-e6.
6. Perlman JM, Risser R, Broyles RS: Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics 1996;97:822-827.
7. Dyet LE, Kennea N, Counsell SJ, Maalouf EF, Ajayi-Obe M, Duggan PJ, et al: Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics 2006;118:536-548.
8. Ajayi-Obe M, Saeed N, Cowan F, Rutherford MA, Edwards AD: Reduced development of cerebral cortex in extremely preterm infants. Lancet 2000;356:1162-1163.
9. Boardman JP, Counsell SJ, Rueckert D, Kapellou O, Bhatia KK, Aljabar P, et al: Abnormal deep grey matter development following preterm birth detected using deformation-based morphometry. Neuroimage 2006;32:70-78.
10. Abernethy LJ, Palaniappan M, Cooke RWI: Quantitative magnetic resonance imaging of the brain in survivors of very low birth weight. Arch Dis Child 2002;87:279-283.
11. Nosarti C, Al Asady MHS, Frangou S, Stewart AL, Rifkin L, Murray RM: Adolescents who were born very preterm have decreased brain volumes. Brain 2002;125:1616-1623.
12. Fearon P, O'Connell P, Frangou S, Aquino P, Nosarti C, Allin M, et al: Brain volumes in adult survivors of very low birth weight: a sibling-controlled study. Pediatrics 2004;114:367-371.
13. Patz A: The role of oxygen in retrolental fibroplasia. Trans Amer Ophth Soc 1968;66:940-985.
14. Salt PJ, Barnes PK, Conway CM: Inhibition of neuronal uptake of noradrenaline in the isolated perfused rat heart by pancuronium and its homologues, ORG 6368, ORG 7268 and NC 45. Br J Anaesth 1980;52:313-317.
15. Collins MP, Lorenz JM, Jetton JR, Paneth N: Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res 2001;50:712-719.
16. Taglialatela G, Pierez-Polo JR, Rassin DK: Induction of apoptosisin the CNS during the development by the combination of hyperoxia and inhibition of glutathione synthesis. Free Radic Biol Med 1998;25:936-942.
17. Ahdab-Barmada M, Moossy J, Nemoto EM, Lin MR: Hyperoxia produces neuronal necrosis in the rat. J Neuropathol Exp Neurol 1986;45:233-246.
18. Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E, Mahler L, et al: Oxygen causes cell death in the developing brain. Neurobiol Dis 2004;17:273-282.
19. Felderhoff-Mueser U, Sifringer M, Polley O, et al: Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol 2005;57:50-59.
20. Kaindl AM, Sifringer M, Zabel C, Nebrich G, Wacker MA, Felderhoff-Mueser U, et al: Acute and long-term proteome changes induced by oxidative stress in the developing brain. Cell Death Differ 2006;13:1097-1109.
21. Dobbing J, Sand J: Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:379-383.
22. Cunningham S, Fleck BW, Elton RA, McIntosh N: Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995;346:1464-1465.
23. Counsell SJ, Shen Y, Boardman JP, Larkman DJ, Kapellou O, Ward P, et al: Axial and radial diffusivity in preterm infants who have diffuse white matter changes on magnetic resonance imaging at term-equivalent age. Pediatrics 2006;117:376-386.
24. Cunningham S, McColm JR, Wade JC, Sedowofia K, McIntosh N, Fleck BW: A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest Ophthalmol Vis Sci 2000;41:4275-4280.
25. McColm J, Cunningham S: The development of a computer controlled system to simulate in rats, the rapid, frequent changes in oxygen experienced by preterm infants developing retinopathy of prematurity. J Med Eng Technol 2000;24:45-52.
26. Mok JYQ, McLaughlin FJ, Pintar M, Hak H, Almaro-Galvez R, Levison H: Transcutaneous monitoring of oxygenation: what is normal. J Paediatr 1986;108:365-371.
27. Vannucci RC, Vannucci SJ: Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci 2005;27:81-86.
28. Sedowofia K, McColm J, Fleck BW, Cunningham S, McIntosh N: Oxygen variability and the developing rat brain. Pediatr Res 2001;49:285.
29. Mooney SM, Miller MW: Expression of bcl-2, bax, and caspase 3 in the brain of the developing rat. Dev Brain Res 2000;123:103-117.
30. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, et al: Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998;18:3659-3668.
31. Bittigau P, Sifringer M, Pohl D, Stadthaus D, Ishimaru M, Shimizu T, et al: Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 1999;45:724-735.
32. Lubec B, Dell'Anna E, Fang-Kircher S, Marx M, Herrera-Marschitz M, Lubec G: Decrease of protein kinase C, protein kinase A, and cyclin-dependent kinase correlating with pH precedes neuronal death in neonatal asphyxia. J Investig Med 1997;45:284-294.
33. Conti AC, Raghupathy R, Trojanowski JQ, McIntosh TK: Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 1998;18:5663-5672.
34. Northington FJ, Ferriero DM, Flock DL, Martin LJ: Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischaemia is apoptosis. J Neurosci 2001;21:1931-1938.
35. Back SA, Han BH, Luo NL, Chricton CA, Anthoudakis S, Tam J, et al: Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischaemia. J Neurosci 2002;22:455-463.
36. Petito CK, Olarte JP, Roberts B, Nowak TS, Pulsinelli WA: Selective glial vulnerability following transient global ischaemia in rat brain. J Neuropathol Exp Neurol 1998;57:231-238.
37. Ness JK, Romanko MJ, Rothstein RP, Wood TL, Levison SW: Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 2001;23:203-208.
38. Uehara H, Yoshioka H, Kawase S, Nagai H, Ohmae T, Hasegawa K, et al: A new model of white matter injury in neonatal rats with bilateral carotid artery occlusion. Brain Res 1999;837:213-220.
39. Cai Z, Pang Y, Xiao F, Rhodes PG: Chronic ischemia preferentially causes white matter injury in the neonatal rat brain. Brain Res 2001;898:126-135.
40. Towfighi J, Yager JY, Housman C, Vannucci RC: Neuropathology of remote hypoxicis-chemic damage in the immature rat. Acta Neuropathol 1991;81:578-587.
41. Roland EH, Poskitt K, Rodriguez E, Lupton BA, Hill A: Perinatal hypoxic-ischaemic thalamic injury: clinical features and neuroimaging. Ann Neurol 1998;44:161-166.
42. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM: Selective vulnerability of subplate neurones after early neonatal hypoxia-ischemia. J Neurosci 2003;23:3308-3315.
43. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC: Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21:1302-1312.
44. Mucke L, Eddleston M: Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J 1993;7:1226-1232.
45. Hatfield JS, Skoff RP: GFAP immunoreactivity reveals astrogliosis in females heterozygous for jimpy. Brain Res 1982;250:123-131.
46. Li XS, Bartlett WP: Developmental expression of glial fibrillary acidic protein and glutamine synthetase mRNAs in normal and jimpy mice. Brain Res Mol Brain Res 1991;9:313-917.
47. Mathis C, Hindelang C, LeMur M, Borrelli E: A transgenic mouse model for inducible and reversible dysmyelination. J Neurosci 2000;20:7698-7705.
48. Johnson ES, Ludwin SK: The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol 1981;53:93-98.
49. Penderis J, Shields SA, Franklin RJM: Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 2003;126:1382-1391.
50. Linington C, Engelhardt B, Kapocs G, Lassman H: Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992;40:219-224.
51. Herndon R, Price DL, Weiner L: Regeneration of oligodendroglia during recovery from demyelinating disease. Science 1977;195:693-694.
52. Mandai K, Matsuoka M, Kitagawa K, Matsushita K, Ohtsuki T, et al: Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience 1997;77:849-861.
53. Liu Y, Siverstein FS, Skoff RP, Barks JDE: Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 2002;51:25-33.
54. Pharoah PO, Platt MJ, Cooke T: The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996;75:F169-F173.
55. Hagberg B, Hagberg G, Beckung E, Uvebrant P: Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94. Acta Paediatr 2001;90:271-277.
56. Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, Klein N: Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002;346:149-157.
57. Hoehn T, Felderhoff-Mueser U, Maschewski K, Stadelmann C, Sifringer M, Bittigau P, et al: Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain. Pediatr Res 2003;54:179-184.
58. Kripke C: Room air vs. oxygen for resuscitating infants at birth. Am Fam Physician 2005;72:808.
59. Askie LM, Henderson-Smart DJ: Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev 2000;CD001077.
60. Inder TE, Mocatta T, Darlow B, Spencer C, Volpe JJ: Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediat Res 2002;52:213-218.